Pfizer Inc. and the company's German partner BioNTech SE submitted to U.S. regulators the initial data from an early-stage trial toward seeking authorization of a booster...
Pfizer and BioNTech have formally asked for FDA approval of a third dose of their COVID-19 vaccine BNT162b2
Scientists have used an adaptation of the genome editing technology CRISPR to develop a new tool that can identify antibodies to SARS-CoV-2 in patient blood samples....
Given the dire situation of the pandemic, could these health care stocks be top stocks to watch this week? The post 4 Health Care Stocks To...
A single dose of a monoclonal antibody developed by scientists at the US National Institutes of Health (NIH) The post More malaria hope as NIH antibody...
New Studies Suggest Lambda Variant Could Be Vaccine-Resistant Two separate studies have concluded that the latest Covid-19 fearpocalypse - the Lambda strain - may be vaccine...
The U.S. Food and Drug Administration is expected to announce that the regulatory agency is authorizing the use of a booster shot for the Pfizer-BioNTech and...
Best trending penny stocks to watch now? Check these 3 out for your watchlist The post Trending Penny Stocks to Buy Now? 3 Small-Caps to Watch...
The Delta variant has demonstrated a likely course for our COVID future – a new endemic piece of the global human microbiome puzzle. It’s not the...
COVID-19 Testing Should Be Clinically-Driven, UK lawmakers Told Authored by Lily Zhou via The Epoch Times, The UK should stop the community testing for COVID-19, and...
Antibody levels are a good predictor for how effective Moderna Inc.'s Covid-19 vaccine is, according to a new study released on Aug. 10, a finding which...
South Korea’s SK Bioscience has been given the all-clear to start a phase 3 trial of its COVID-19 The post SK Bio’s COVID vaccine will start...
Two Vaccine Doses? Why Not Three? Authored by Ethan Yang via The American Institute for Economic Research, On July 28, CNN reported that Pfizer, one of the primary...
Being immunocompromised appears to affect the vaccine response, but this seems to vary depending on the causes of the person’s low immunity.
The mRNA vaccine from Pfizer and BioNTech may be less effective than Moderna's against the Delta variant of the coronavirus, according to two reports posted on...
Canadian Refused Entry To Own Country Despite Proving Strong Natural COVID Immunity And Negative Tests Authored by Steve Watson via Summit News, A Canadian writer who...
Would these vaccine stocks make for good investments amidst the current wave of coronavirus infections? The post Best Stocks To Buy Now? 4 Vaccine Stocks To...
Novavax Inc. on Aug. 5 again delayed the company's timeline for seeking U.S. authorization for its two-dose Covid-19 vaccine, but expects to become a major distributor...
Antibody levels in people inoculated with CanSino Biologics' (CanSinoBIO) single-dose Covid-19 vaccine fell by some 30 percent after six months, however a booster shot could offer...
FDA Reportedly Planning For COVID Vaccine Booster Shot Approval By September Update (1640ET): Confirming what we have all suspected (and The White House, France, and Germany...
'A Variant Worse Than Delta': Fauci Dials Fear To 11 As Emerging 'Lambda' Strain Appears More Resistant To Vaccine Dr. Anthony Fauci, the country's top infectious...
Biotech penny stocks are heating up right now; here's 3 to watch The post Best Biotech Penny Stocks For Your Small-Caps Watchlist Right Now appeared first...
In this webinar from GEN, The CRISPR Journal, and sponsored by TriLink, Professor Dan Peer will discuss the state of RNA-based therapeutics, particularly developing a self-assembled...
The UK government has confirmed that the national COVID-19 vaccination campaign will be extended to include 16 and The post UK extends COVID vaccination to 16...
The Delta variant is surging as case numbers hit new highs in many countries around the world, including the US. One of the dynamics that has...
The two companies are collaborating in the development of mRNA vaccines for SARS-CoV-2 and seasonal influenza, but the deal signals Sanofi's desire to advance the mRNA...
- by New Deal democratIt seems pretty clear that Delta burns through the dry tinder very fast - on the order of 9 to 12 weeks...
Translate Bio is partnering with Sanofi in developing MRT5500, an mRNA vaccine based on Translate’s proprietary MRT™ platform, which it acquired from Shire in 2017.
Finally, Australia’s vaccine rollout is beginning to gain traction. In July, around 4.5 million vaccinations were administered – more than double the rate achieved in May....
Investors could be shifting their focus to biotech stocks, should you do the same? The post 4 Biotech Stocks For Your August 2021 Watchlist appeared first...